Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: Hep Editors on May 08, 2018, 10:33:17 am
-
Dutch clinicians in a recent study apparently did a good job of negotiating potential harmful drug-drug interactions (DDIs) between antiretroviral (ARV) treatments for HIV and direct-acting antiviral (DAA) treatments for hepatitis C virus (HCV) among those coinfected with both viruses. However, researchers found that these health care providers could do a better job of preventing pairings of DAAs and contraindicated non-HIV medications.
Use of two drugs in combination is considered contraindicated, or ill advised, when research indicates such a combination could be harmful.
Read more...
https://www.hepmag.com/article/docs-manage-potential-conflicts-hep-c-hiv-meds